Elly Marcq

Has grant

Vrije Universiteit Brussel

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Immunology Immunology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Investigation of PD-1 and its ligands as novel therapeutic strategy for the treatment of MPM

Open Date: 2015-01-01

Close Date: 2018-12-01

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (15)

Winnok H. De Vos

BELGIUM

View details

Tracy Hoang

University in Western Australia

AUSTRALIA

View details

Christophe Deben

University of Antwerp

BELGIUM

View details

Jonathan Chee

University of Western Australia

AUSTRALIA

View details

Grant Morahan

Emeritus Professor

University in Western Australia

AUSTRALIA

View details

Jo Raskin

Antwerp University Hospital

BELGIUM

View details

Ben Wylie

University of Western Australia

AUSTRALIA

View details

Willem Joost Lesterhuis

University of Western Australia

AUSTRALIA

View details

Scott Fisher

University of Western Australia

AUSTRALIA

View details

Guido R. Y. De Meyer

University of Antwerp

BELGIUM

View details

Mariana Lizeth Orozco Morales

University of Western Australia

AUSTRALIA

View details

Wim Martinet

Professor

University of Antwerp

BELGIUM

View details

Kimberley Burton

University of Western Australia

AUSTRALIA

View details

Kevin Lamote

Assistant professor

University of Antwerp

BELGIUM

View details

Nicola Principe

University in Western Australia

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elly Marcq

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (14)

A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice

The MexTAg collaborative cross

Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade

IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.

Determining the clinical utility of a breath test for screening an asbestos-exposed population for Pleural Mesothelioma: Baseline results

Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers

Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer

PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomas.

External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma

Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma

Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model

The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3

NTRK Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?

Collaborators (15)

Winnok H. De Vos

Tracy Hoang

Christophe Deben

Jonathan Chee

Grant Morahan

Jo Raskin

Ben Wylie

Willem Joost Lesterhuis

Scott Fisher

Guido R. Y. De Meyer

Mariana Lizeth Orozco Morales

Wim Martinet

Kimberley Burton

Kevin Lamote

Nicola Principe

Make your next move.